MSB 3.21% $1.13 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-170

  1. 7,144 Posts.
    lightbulb Created with Sketch. 1324
    If we get FDA approval next quarter, as inferred, we are in for a big year.

    MESO will be interesting tonight.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.